Cytek Biosciences Stock Price on December 31, 2023
| CTKB Stock | USD 6.53 0.03 0.46% |
If you're considering investing in Cytek Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cytek Biosciences stands at 6.53, as last reported on the 1st of December, with the highest price reaching 6.61 and the lowest price hitting 6.46 during the day. Cytek Biosciences appears to be moderately volatile, given 3 months investment horizon. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of 0.0778, which signifies that the company had a 0.0778% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cytek Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Cytek Biosciences' Downside Deviation of 4.23, risk adjusted performance of 0.0566, and Mean Deviation of 3.19 to double-check if our risk estimates are consistent with your expectations.
At present, Cytek Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 23.2 M, whereas Total Stockholder Equity is forecasted to decline to about 256.8 M. . At present, Cytek Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.19, whereas Price To Sales Ratio is forecasted to decline to 6.07. Cytek Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cytek |
Sharpe Ratio = 0.0778
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CTKB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.68 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Cytek Biosciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytek Biosciences by adding it to a well-diversified portfolio.
Price Book 2.1821 | Enterprise Value Ebitda (133.96) | Price Sales 4.1804 | Shares Float 110.7 M | Wall Street Target Price 8.4 |
Cytek Biosciences Valuation on December 31, 2023
It is possible to determine the worth of Cytek Biosciences on a given historical date. On December 31, 2023 Cytek was worth 9.39 at the beginning of the trading date compared to the closed value of 9.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cytek Biosciences stock. Still, in general, we apply an absolute valuation method to find Cytek Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytek Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cytek Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 9.42 | 9.52 | 9.00 | 9.45 | 416,300 | |
12/29/2023 | 9.39 | 9.49 | 9.10 | 9.12 | 754,100 |
| 8.99 | 9.19 | 8.72 | 8.87 | 746,700 |
| Backtest Cytek Biosciences | | | Cytek Biosciences History | | | Cytek Biosciences Valuation | Previous | Next |
Cytek Biosciences Trading Date Momentum on December 31, 2023
| On January 02 2024 Cytek Biosciences was traded for 8.87 at the closing time. The top price for the day was 9.19 and the lowest listed price was 8.72 . The trading volume for the day was 746.7 K. The trading history from January 2, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.74% . The overall trading delta against the current closing price is 12.28% . |
Cytek Biosciences Fundamentals Correlations and Trends
By evaluating Cytek Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cytek Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cytek financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cytek Biosciences Stock history
Cytek Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytek is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytek Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytek Biosciences stock prices may prove useful in developing a viable investing in Cytek Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 135.3 M | 148.2 M | |
| Net Income Applicable To Common Shares | 3 M | 3.1 M |
Cytek Biosciences Quarterly Net Working Capital |
|
Cytek Biosciences Stock Technical Analysis
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cytek Biosciences Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Cytek Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cytek Biosciences December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Cytek Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytek Biosciences shares will generate the highest return on investment. By undertsting and applying Cytek Biosciences stock market strength indicators, traders can identify Cytek Biosciences entry and exit signals to maximize returns
Cytek Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytek Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cytek Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytek to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0566 | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0514 | |||
| Treynor Ratio | 0.0723 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |